5I73 image
Entry Detail
PDB ID:
5I73
Title:
X-ray structure of the ts3 human serotonin transporter complexed with s-citalopram at the central and allosteric sites
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2016-02-16
Release Date:
2016-04-13
Method Details:
Experimental Method:
Resolution:
3.24 Å
R-Value Free:
0.27
R-Value Work:
0.23
R-Value Observed:
0.23
Space Group:
C 2 2 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Sodium-dependent serotonin transporter
Chain IDs:A
Chain Length:549
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:8B6 antibody, heavy chain
Chain IDs:B
Chain Length:221
Number of Molecules:1
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Description:8B6 antibody, light chain
Chain IDs:C
Chain Length:214
Number of Molecules:1
Biological Source:Mus musculus
Primary Citation
X-ray structures and mechanism of the human serotonin transporter.
Nature 532 334 339 (2016)
PMID: 27049939 DOI: 10.1038/nature17629

Abstact

The serotonin transporter (SERT) terminates serotonergic signalling through the sodium- and chloride-dependent reuptake of neurotransmitter into presynaptic neurons. SERT is a target for antidepressant and psychostimulant drugs, which block reuptake and prolong neurotransmitter signalling. Here we report X-ray crystallographic structures of human SERT at 3.15 Å resolution bound to the antidepressants (S)-citalopram or paroxetine. Antidepressants lock SERT in an outward-open conformation by lodging in the central binding site, located between transmembrane helices 1, 3, 6, 8 and 10, directly blocking serotonin binding. We further identify the location of an allosteric site in the complex as residing at the periphery of the extracellular vestibule, interposed between extracellular loops 4 and 6 and transmembrane helices 1, 6, 10 and 11. Occupancy of the allosteric site sterically hinders ligand unbinding from the central site, providing an explanation for the action of (S)-citalopram as an allosteric ligand. These structures define the mechanism of antidepressant action in SERT, and provide blueprints for future drug design.

Legend

Protein

Chemical

Disease

Primary Citation of related structures